Search

Your search keyword '"Amant, Frederic"' showing total 19 results
Start Over Author "Amant, Frederic" Publisher bmj
19 results on '"Amant, Frederic"'

1. Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study

Author

Struys, Ilana, primary, Velázquez, Carolina, additional, Devriendt, Koenraad, additional, Godderis, Lode, additional, Segers, Heidi, additional, Thienpont, Bernard, additional, van Boxtel, Ruben, additional, Van Calsteren, Kristel, additional, Voet, Thierry, additional, Wolters, Vera, additional, Lenaerts, Liesbeth, additional, and Amant, Frederic, additional

Published
2024
Full Text
View/download PDF

3. FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study

Author

Plante, Marie, primary, van Trommel, Nienke, additional, Lheureux, Stephanie, additional, Oza, Amit M, additional, Wang, Lisa, additional, Sikorska, Karolina, additional, Ferguson, Sarah Elizabeth, additional, Han, Kathy, additional, and Amant, Frederic, additional

Published
2019
Full Text
View/download PDF

4. Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy

Author

Halaska, Michael J, primary, Uzan, Catherine, additional, Han, Sileny N, additional, Fruscio, Robert, additional, Dahl Steffensen, Karina, additional, Van Calster, Ben, additional, Stankusova, Hana, additional, Marchette, Martina Delle, additional, Mephon, Astrid, additional, Rouzier, Roman, additional, Witteveen, Petronella O, additional, Vergani, Patrizia, additional, Van Calsteren, Kristina, additional, Rob, Lukas, additional, and Amant, Frederic, additional

Published
2019
Full Text
View/download PDF

5. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study

Author

van der Putten, Louis J.M., primary, Visser, Nicole C.M., additional, van de Vijver, Koen, additional, Santacana, Maria, additional, Bronsert, Peter, additional, Bulten, Johan, additional, Hirschfeld, Marc, additional, Colas, Eva, additional, Gil-Moreno, Antonio, additional, Garcia, Angel, additional, Mancebo, Gemma, additional, Alameda, Fransesc, additional, Trovik, Jone, additional, Kopperud, Reidun K., additional, Huvila, Jutta, additional, Schrauwen, Stefanie, additional, Koskas, Martin, additional, Walker, Francine, additional, Weinberger, Vit, additional, Minar, Lubos, additional, Jandakova, Eva, additional, Snijders, Marc P.L.M., additional, van den Berg-van Erp, Saskia, additional, Matias-Guiu, Xavier, additional, Salvesen, Helga B., additional, Werner, Henrica M.J., additional, Amant, Frederic, additional, Massuger, Leon F.A.G., additional, and Pijnenborg, Johanna M.A., additional

Published
2018
Full Text
View/download PDF

6. Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study

Author

Dackus, Gwen MHE, primary, ter Hoeve, Natalie D, additional, Opdam, Mark, additional, Vreuls, Willem, additional, Varga, Zsuzsanna, additional, Koop, Esther, additional, Willems, Stefan M, additional, Van Deurzen, Carolien HM, additional, Groen, Emilie J, additional, Cordoba, Alicia, additional, Bart, Jos, additional, Mooyaart, Antien L, additional, van den Tweel, Jan G, additional, Zolota, Vicky, additional, Wesseling, Jelle, additional, Sapino, Anna, additional, Chmielik, Ewa, additional, Ryska, Ales, additional, Amant, Frederic, additional, Broeks, Annegien, additional, Kerkhoven, Ron, additional, Stathonikos, Nikolas, additional, Veta, Mitko, additional, Voogd, Adri, additional, Jozwiak, Katarzyna, additional, Hauptmann, Michael, additional, Hoogstraat, Marlous, additional, Schmidt, Marjanka K, additional, Sonke, Gabe, additional, van der Wall, Elsken, additional, Siesling, Sabine, additional, van Diest, Paul J, additional, and Linn, Sabine C, additional

Published
2017
Full Text
View/download PDF

9. Synchronous Ovarian and Endometrial Cancer—an International Multicenter Case-Control Study

Author

Heitz, Florian, primary, Amant, Frederic, additional, Fotopoulou, Christina, additional, Battista, Marco J., additional, Wimberger, Pauline, additional, Traut, Alexander, additional, Fisseler-Eckhoff, Annette, additional, Harter, Philipp, additional, Vandenput, Ingrid, additional, Sehouli, Jalid, additional, Schmidt, Marcus, additional, Kimmig, Rainer, additional, du Bois, Rabea, additional, and du Bois, Andreas, additional

Published
2014
Full Text
View/download PDF

10. Pelvic Exenterations for Gynecological Malignancies

Author

Kaur, Manpreet, primary, Joniau, Steven, additional, D’Hoore, André, additional, Van Calster, Ben, additional, Van Limbergen, Erik, additional, Leunen, Karin, additional, Penninckx, Freddy, additional, Van Poppel, Hendrik, additional, Amant, Frederic, additional, and Vergote, Ignace, additional

Published
2012
Full Text
View/download PDF

12. ESGO Statement on the Role of CA‐125 Measurement in Follow-Up of Epithelial Ovarian Cancer

Author

Colombo, Nicoletta, primary, Gitsch, Gerald, additional, Reed, Nicolas, additional, Amant, Frederic, additional, Cibula, David, additional, Kesic, Vesna I., additional, Kimmig, Rainer, additional, Lopes, Alberto D.B., additional, Markowska, Janina, additional, Marth, Christian, additional, Radolakis, Alexander, additional, Salvesen, Helga, additional, Vaitkiene, Daiva, additional, Verheijen, René H.M., additional, Zola, Paolo, additional, and van der Zee, Ate G.J., additional

Published
2012
Full Text
View/download PDF

14. Training in Bowel and Upper Abdominal Surgery in Gynaecological Oncology

Author

Cibula, David, primary, Verheijen, Rene, additional, Lopes, Alberto, additional, Amant, Frederic, additional, Beller, Uziel, additional, Colombo, Nicoletta, additional, Gitsch, Gerald, additional, Kesic, Vesna, additional, Kimmig, Rainer, additional, Markowska, Janina, additional, Marth, Christian, additional, Reed, Nicholas, additional, Rodolakis, Alexandros, additional, Salvesen, Helga, additional, Vaitkiene, Daiva, additional, van der Zee, Ate G.J., additional, and Zola, Paolo, additional

Published
2011
Full Text
View/download PDF

18. ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer.

Author

van der Zee AG, Colombo N, Gitsch G, Reed N, Amant F, Cibula D, Kesic VI, Kimmig R, Lopes AD, Markowska J, Marth C, Radolakis A, Salvesen H, Vaitkiene D, Verheijen RH, and Zola P

Subjects
Carcinoma, Ovarian Epithelial, Female, Humans, CA-125 Antigen metabolism, Neoplasm Recurrence, Local diagnosis, Neoplasms, Glandular and Epithelial metabolism, Ovarian Neoplasms metabolism
Published
2012
Full Text
View/download PDF

19. Fertility preserving management in gynecologic cancer patients: the need for centralization.

Author

Kesic V, Rodolakis A, Denschlag D, Schneider A, Morice P, Amant F, and Reed N

Subjects
Adult, Advisory Committees organization & administration, Data Collection, Female, Fertility physiology, Gynecology methods, Gynecology organization & administration, Humans, Medical Oncology methods, Medical Oncology organization & administration, Middle Aged, Pregnancy, Retrospective Studies, Surveys and Questionnaires, Centralized Hospital Services organization & administration, Genital Neoplasms, Female therapy, Health Services Needs and Demand statistics & numerical data, Infertility, Female prevention & control
Abstract

Preservation of fertility has became a very important issue in gynecologic oncology. It is a result of both the increasing incidence of gynecologic cancer in young patients and the increasing age at first pregnancy. Today, in a young patient with a gynecologic cancer, preservation of fertility is possible and depends primarily on the extent and type of cancer. The clinical importance of an appropriate management of young patients with gynecologic cancer has lead the ESGO Task Force for Fertility Preservation in Gynecologic Cancer to conduct a survey with the aim of exploring the numbers and eligibility of gynecologic cancer patients for fertility-sparing treatment in selected gynecologic oncology centers across Europe. A questionnaire designed to allow adequate insight into the number of patient eligible for fertility-sparing treatment and the resulting treatment was sent to 20 ESGO-accredited centers. The data were collected retrospectively for the year 2007. The reply was received from 14 gynecologic oncology centers, and those surveys were included for analysis. The small numbers of patients eligible for conservative management (14-15 per year/median number in ESGO-accredited centers) and even the smaller number of those who actually receive fertility-sparing treatment (<10) raise the question of quality of care for these patients. These low numbers support the concept of centralization for fertility-sparing management to improve the quality of patients care. Since carrying out the survey on fertility-sparing management in ESGO-accredited gynecologic oncology centers in Europe, the ESGO Task Force for Fertility Preservation in Gynecologic Cancer has proposed a protocol for referrals to centralized units that have developed specific expertise. Optimal management for young patients with gynecologic cancer should include a clear decision-making process, an adequate counseling about the future oncological and obstetrical risks, the appropriate management, and a careful follow-up within a multidisciplinary setting.

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results